ELV
LHX

Lewis Hay III

Known title: DirectorCIK: 0001182705

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Elevance Health Q3 Outlook: Premium Pressures and Sector Peer Trends. Elevance Health is preparing for its third-quarter earnings report, with analysts examining key metrics and the potential impact of lower premiums on the company's results. Broader sector news highlights peers like UnitedHealth, Centene, and Oscar Health pursuing growth and cost-saving strategies amidst shifting premium dynamics. The market is observing how these competitive and industry-wide pressures will align with Elevance Health's upcoming performance.

this person other insiders at ELV

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

L3Harris Faces Analyst Target Cuts Amid Defense Sector Volatility. Recent analyst notes show shifting price targets for L3Harris, with firms lowering estimates amid broader defense sector pressures. While sector-wide stock declines have created headwinds, the company's ongoing R&D investments remain a focal point for technology innovation. The varying analyst targets highlight current market uncertainty surrounding major defense contractors.

this person other insiders at LHX

Transaction History

ELV▲ Buy$0
LHX▲ Buy$0
ELV▲ Buy$0
LHX▲ Buy$0
ELV▲ Buy$0
LHX▲ Buy$0
ELV▲ Buy$0
LHX▲ Buy$0
LHX▲ Buy$0
ELV▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.